Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B

Chronic hepatitis B is caused by prolonged infection with the hepatitis B virus (HBV), which can substantially increase the risk of developing liver disease. Despite the development of preventive vaccines against HBV, a therapeutic vaccine inducing an effective antibody response still remains elusiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenjun, Zhou, Xiaoxiao, Bian, Yingjie, Wang, Shan, Chai, Qian, Guo, Zhenqian, Wang, Zhenni, Zhu, Ping, Peng, Hua, Yan, Xiyun, Li, Wenhui, Fu, Yang-Xin, Zhu, Mingzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223715/
https://www.ncbi.nlm.nih.gov/pubmed/32123380
http://dx.doi.org/10.1038/s41565-020-0648-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223715/
https://www.ncbi.nlm.nih.gov/pubmed/32123380
http://dx.doi.org/10.1038/s41565-020-0648-y

Ejemplares similares